V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160353 | 20061779 | 1.82 | 61 | Palliative (P) | 2017-06-25 | 2017-07-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101548645 |
| 20160354 | 20061780 | null | null | Palliative (P) | 2016-06-06 | 2016-06-26 | ECX | N | N | ECX | 100984841 |
| 20160358 | 20061781 | 1.53 | 62.2 | Neo-adjuvant (N) | 2019-07-23 | 2019-08-08 | ECX | 2 | N | ECX | 100115203 |
| 20160359 | 20061782 | 1.76 | 76.4 | Adjuvant (A) | 2018-06-12 | 2018-07-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101356100 |
| 20160361 | 20061783 | 1.58 | 53.1 | Palliative (P) | null | 2017-01-07 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101361421 |
| 20160363 | 20061784 | 1.67 | 85.5 | Adjuvant (A) | 2017-08-25 | 2017-09-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100983068 |
| 20160365 | 20061785 | 1.69 | 73.9 | Palliative (P) | 2018-07-14 | 2018-08-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100395887 |
| 20160366 | 20061786 | 1.74 | 85 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-07 | ECX | N | N | ECX | 101146178 |
| 20160367 | 20061787 | 1.51 | 78.6 | Palliative (P) | 2019-03-06 | 2019-03-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101155212 |
| 20160369 | 20061788 | 1.75 | 64.9 | Neo-adjuvant (N) | 2018-04-12 | 2018-04-26 | ECX | 02 | N | ECX | 101517297 |
| 20160372 | 20061789 | 1.76 | 66.4 | Palliative (P) | 2019-09-20 | 2019-09-28 | Gemcitabine + Capecitabine | null | N | ECX | 100109985 |
| 20160373 | 20061790 | 1.7 | 99.8 | Neo-adjuvant (N) | 2018-12-29 | 2018-12-31 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101053748 |
| 20160374 | 20061791 | 1.69 | 60.8 | Palliative (P) | 2016-01-09 | 2016-03-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101406043 |
| 20160376 | 20061792 | 1.7 | 68.5 | null | 2017-01-04 | 2017-01-04 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100243656 |
| 20160378 | 20061793 | 1.76 | 68 | Palliative (P) | null | 2018-04-09 | ECX | 02 | null | ECX | 101030906 |
| 20160380 | 20061794 | 1.73 | 87.7 | Neo-adjuvant (N) | 2017-06-06 | 2017-06-13 | ECX | N | N | ECX | 100229058 |
| 20160381 | 20061795 | 1.64 | 88 | Adjuvant (A) | 2017-07-17 | 2017-07-31 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100457564 |
| 20160382 | 20061796 | 1.68 | 67.4 | null | 2019-10-02 | 2019-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100491192 |
| 20160383 | 20061797 | 1.52 | 75 | 03 | 2016-09-25 | 2016-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100457451 |
| 20160388 | 20061798 | 1.62 | 62.1 | Neo-adjuvant (N) | 2016-07-18 | 2016-07-24 | ECX | N | N | ECX | 101430740 |
| 20160389 | 20061799 | 1.8 | 60 | Palliative (P) | 2017-03-16 | 2017-03-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101339977 |
| 20160392 | 20061800 | 1.64 | 84.9 | Adjuvant (A) | 2017-11-20 | 2017-12-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100493689 |
| 20160395 | 20061801 | 1.63 | 108 | Neo-adjuvant (N) | 2018-03-08 | 2018-03-08 | Gemcitabine + Capecitabine | N | N | ECX | 100064420 |
| 20160396 | 20061802 | 1.74 | 55.7 | Neo-adjuvant (N) | 2019-01-27 | 2019-01-29 | ECX | 02 | N | ECX | 100386258 |
| 20160398 | 20061803 | 1.72 | 61 | Neo-adjuvant (N) | 2018-01-22 | 2018-02-01 | ECX | 02 | N | ECX | 101257398 |
| 20160400 | 20061804 | 1.71 | 76 | Neo-adjuvant (N) | 2018-04-02 | 2018-04-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101550076 |
| 20160401 | 20061805 | 1.77 | 101.2 | Curative (C) | 2017-04-10 | 2017-04-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100799598 |
| 20160403 | 20061806 | 1.79 | 78.3 | Neo-adjuvant (N) | 2019-07-22 | 2019-07-25 | ECX | N | N | ECX | 101593416 |
| 20160404 | 20061807 | 1.51 | 90 | Neo-adjuvant (N) | 2018-12-03 | 2018-12-14 | ECX | N | N | ECX | 100312227 |
| 20160405 | 20061808 | 1.71 | 85.3 | Neo-adjuvant (N) | 2019-12-05 | 2019-12-27 | ECX | N | N | ECX | 100949705 |
| 20160410 | 20061809 | 1.75 | 70.9 | Neo-adjuvant (N) | 2018-01-25 | 2018-02-01 | ECX | 2 | N | ECX | 101018633 |
| 20160411 | 20061810 | 1.6 | 76.5 | Palliative (P) | 2017-03-04 | 2017-03-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100330972 |
| 20160412 | 20061811 | 1.78 | 95.6 | Neo-adjuvant (N) | 2018-11-29 | 2019-01-06 | ECX | 02 | Y | ECX | 101182799 |
| 20160414 | 20061812 | 1.71 | 58.6 | Palliative (P) | 2017-11-07 | 2017-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100131920 |
| 20160415 | 20061813 | 1.8 | 86.1 | Adjuvant (A) | 2017-02-23 | 2017-03-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101852864 |
| 20160417 | 20061814 | 1.68 | 66.8 | null | null | 2019-04-11 | ECX | null | N | ECX | 101723264 |
| 20160418 | 20061815 | 1.75 | 84.8 | Palliative (P) | 2016-07-30 | 2016-08-18 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100181993 |
| 20160420 | 20061816 | 1.63 | 59 | Palliative (P) | 2017-09-18 | 2017-09-25 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100712051 |
| 20160422 | 20061817 | 1.73 | 100.8 | Adjuvant (A) | 2018-09-09 | 2018-09-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100748038 |
| 20160423 | 20061818 | 1.78 | 114.3 | Adjuvant (A) | 2017-04-08 | 2017-04-11 | ECX | null | Y | ECX | 101488368 |
| 20160424 | 20061819 | 1.7 | 76.2 | Adjuvant (A) | 2016-04-05 | 2016-04-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100384652 |
| 20160425 | 20061820 | 1.5 | 102.2 | Neo-adjuvant (N) | 2016-09-26 | 2016-10-08 | ECX | N | N | ECX | 101551946 |
| 20160426 | 20061821 | 1.6 | 95.5 | Neo-adjuvant (N) | 2016-12-16 | 2016-12-16 | ECX | 02 | null | ECX | 101197857 |
| 20160427 | 20061822 | 1.84 | 65.7 | Neo-adjuvant (N) | 2016-06-10 | 2016-06-10 | ECX | N | N | ECX | 100886655 |
| 20160428 | 20061823 | 1.59 | 85 | Neo-adjuvant (N) | 2019-06-23 | 2019-07-07 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101545133 |
| 20160429 | 20061824 | 1.58 | 69.7 | Neo-adjuvant (N) | 2019-03-14 | 2019-03-28 | ECX | N | N | ECX | 101162917 |
| 20160430 | 20061825 | 1.68 | 76.4 | Neo-adjuvant (N) | 2017-08-21 | 2017-08-22 | ECX | 02 | N | ECX | 100861390 |
| 20160431 | 20061826 | 1.77 | 73.9 | Neo-adjuvant (N) | 2019-11-11 | 2019-12-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101422755 |
| 20160432 | 20061827 | 1.56 | 47 | Palliative (P) | 2017-10-25 | 2017-10-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100758583 |
| 20160433 | 20061828 | null | null | Palliative (P) | null | 2016-12-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100489162 |